Literature DB >> 19201834

CD8+ T cell responses to a viral escape mutant epitope: active suppression via altered SHP-1 activity.

Frederick J Schnell1, Noah Alberts-Grill, Brian D Evavold.   

Abstract

One mechanism viruses use to subvert immune surveillance is through mutation of MHC contact residues of antigenic epitopes that weaken T cell recognition to the point that the immune system is ignorant of the infection. However, in contrast to ignorance, results presented herein demonstrate that intracellular signaling does occur upon stimulation with a lymphocytic choriomeningitis virus-derived escape mutant as demonstrated by the sustained activation of Src homology 2 domain-containing protein tyrosine phosphatase (SHP-1). In addition to the increased SHP-1 activity, we found that the mutated epitope failed to induce oxidation of SHP-1, further enhancing enzymatic activity. Sustained activation of SHP-1 in a reduced form correlated with ERK and early growth response gene 1 activation and failure of T cells to commit to the effector lineage. Thus, instead of immune ignorance, these studies demonstrate the activation of a negative signaling pathway that actively suppresses T cell responses and limits recognition of viral escape mutants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201834     DOI: 10.4049/jimmunol.0801798

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection.

Authors:  Ryan J Martinez; Anna B Morris; Dennis K Neeld; Brian D Evavold
Journal:  Eur J Immunol       Date:  2016-09       Impact factor: 5.532

2.  The nonphagocytic NADPH oxidase Duox1 mediates a positive feedback loop during T cell receptor signaling.

Authors:  Jaeyul Kwon; Kristen E Shatynski; Haiyan Chen; Stanislas Morand; Xavier de Deken; Françoise Miot; Thomas L Leto; Mark S Williams
Journal:  Sci Signal       Date:  2010-08-03       Impact factor: 8.192

Review 3.  Cross-reactivity of T cells and its role in the immune system.

Authors:  Galina Petrova; Andrea Ferrante; Jack Gorski
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 4.  T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

5.  Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  J Autoimmun       Date:  2013-07-26       Impact factor: 7.094

6.  Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.

Authors:  Maria Bettini; Kristen Rosenthal; Brian D Evavold
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

7.  Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.

Authors:  Ingunn M Stromnes; Carla Fowler; Chanel C Casamina; Christina M Georgopolos; Megan S McAfee; Thomas M Schmitt; Xiaoxia Tan; Tae-Don Kim; Inpyo Choi; Joseph N Blattman; Philip D Greenberg
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

8.  Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics.

Authors:  Kristen M Rosenthal; Lindsay J Edwards; Joseph J Sabatino; Jennifer D Hood; Heather A Wasserman; Cheng Zhu; Brian D Evavold
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

Review 9.  Manipulating the TCR signaling network for cellular immunotherapy: Challenges & opportunities.

Authors:  Courtney A Matson; Nevil J Singh
Journal:  Mol Immunol       Date:  2020-05-15       Impact factor: 4.174

10.  Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses.

Authors:  Shayla K Shorter; Frederick J Schnell; Sean R McMaster; David F Pinelli; Rakieb Andargachew; Brian D Evavold
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.